{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:27:48Z","timestamp":1788917268735,"version":"build-2803163510"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cyto.2024.156732","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T03:01:44Z","timestamp":1723172504000},"page":"156732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus"],"prefix":"10.1016","volume":"182","author":[{"given":"Heba H.","family":"Bakery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaziz S.A.","family":"Abuelsaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0005","article-title":"Interleukin 35: protective role and mechanism in type 1 diabetes","volume":"48","author":"Zhang","year":"2023","journal-title":"Cent. Eur. J. Immunol."},{"issue":"9911","key":"10.1016\/j.cyto.2024.156732_b0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc16-2121","article-title":"Increased interleukin-35 levels in patients with type 1 diabetes with remaining C-peptide","volume":"40","author":"Espes","year":"2017","journal-title":"Diabetes Care"},{"issue":"10138","key":"10.1016\/j.cyto.2024.156732_b0020","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156732_b0025","unstructured":"(IDF), I.D.F., last update 2021-12-9."},{"key":"10.1016\/j.cyto.2024.156732_b0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2741\/3657","article-title":"T helper 17 cells interplay with CD4+ CD25highFoxp3+ Tregs in regulation of inflammations and autoimmune diseases","volume":"15","author":"Mai","year":"2010","journal-title":"Front Biosci"},{"key":"10.1016\/j.cyto.2024.156732_b0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0045","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038989","article-title":"Prominent contribution of Th1, Th17, and Tregs to the host response during M. neoaurum infection","volume":"15","author":"Wang","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/ajt.14148","article-title":"Association of higher CD 4+ CD 25high CD 127low, FoxP3+, and IL-2+ T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years","volume":"17","author":"Salman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cyto.2024.156732_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1753465816669662","article-title":"Applications and mechanisms of immunotherapy in allergic rhinitis and asthma","volume":"11","author":"Kappen","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.cyto.2024.156732_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109829","article-title":"Th2 cell clonal expansion at diagnosis in human type 1 diabetes","volume":"257","author":"Narsale","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.148003","article-title":"Epigallocatechin-3-gallate maintains Th1\/Th2 response balance and mitigates type-1 autoimmune diabetes induced by streptozotocin through promoting the effect of bone-marrow-derived mesenchymal stem cells","volume":"894","author":"Ahmadzadeh","year":"2024","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.cyto.2024.156732_b0075","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20040180","article-title":"CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes","volume":"199","author":"Tarbell","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20030422","article-title":"Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells","volume":"198","author":"Yamazaki","year":"2003","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0085","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1073\/pnas.0611646104","article-title":"Dendritic cells with TGF-\u03b21 differentiate naive CD4+ CD25\u2212 T cells into islet-protective Foxp3+ regulatory T cells","volume":"104","author":"Luo","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.cyto.2024.156732_b0090","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat. Immunol."},{"issue":"24","key":"10.1016\/j.cyto.2024.156732_b0095","first-page":"6102","article-title":"Indoleamine 2, 3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes","volume":"113","author":"Sharma","year":"2009","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1122","article-title":"Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets","volume":"9","author":"Lu","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/718946","article-title":"Serum IL-17, IL-23, and TGF-\u03b2 levels in type 1 and type 2 diabetic patients and age-matched healthy controls","volume":"2014","author":"Roohi","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0110","first-page":"1","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes\u2013possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","article-title":"Interleukin-35: a potential therapeutic agent for autoimmune diseases","volume":"40","author":"Guan","year":"2017","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12016-015-8468-9","article-title":"IL-35 and autoimmunity: a comprehensive perspective","volume":"49","author":"Choi","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156732_b0125","first-page":"1806","article-title":"Assessing the role of IL-35 in colorectal cancer progression and prognosis","volume":"6","author":"Zeng","year":"2013","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"19","key":"10.1016\/j.cyto.2024.156732_b0130","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1158\/1078-0432.CCR-11-0060","article-title":"Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung CancerEBI3, a novel biomarker for lung cancer","volume":"17","author":"Nishino","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/ATVBAHA.117.310626","article-title":"IL-35 (interleukin-35) suppresses endothelial cell activation by inhibiting mitochondrial reactive oxygen species-mediated site-specific acetylation of H3K14 (histone 3 lysine 14)","volume":"38","author":"Li","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2024.156732_b0140","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231209821","article-title":"Correlation analysis between cytokines\u2019 profile, autoimmune antibodies and the duration of type 1 diabetes: a case control study in a specialized children\u2019s centre in Riyadh","volume":"37","author":"Al-Dubayee","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156732_b0145","doi-asserted-by":"crossref","unstructured":"Z. Luo et al., Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes, 2023.","DOI":"10.21203\/rs.3.rs-3347273\/v1"},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.intimp.2015.10.025","article-title":"IL-35 inhibits acute graft-versus-host disease in a mouse model","volume":"29","author":"Zhang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cts.12891","article-title":"Correlation analysis among the level of IL-35, microvessel density, lymphatic vessel density, and prognosis in non-small cell lung cancer","volume":"14","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"9","key":"10.1016\/j.cyto.2024.156732_b0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/v11090772","article-title":"Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems","volume":"11","author":"Guo","year":"2019","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0170","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0175","first-page":"161","article-title":"IL-35 stabilizes Treg phenotype to protect cardiac allografts in mice","volume":"108","author":"Huang","year":"2024","journal-title":"Transplantation"},{"issue":"6924","key":"10.1016\/j.cyto.2024.156732_b0180","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0190","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcb.29441","article-title":"IL-35, a double-edged sword in cancer","volume":"121","author":"Yazdani","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063967","article-title":"Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0200","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.07.019","article-title":"Interleukin 35 regulatory B cells","volume":"433","author":"Choi","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0215","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115958","article-title":"Targeting IL-12 family cytokines: a potential strategy for type 1 and type 2 diabetes mellitus","volume":"170","author":"Luo","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2024.156732_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156408","article-title":"The dichotomic role of single cytokines: fine-tuning immune responses","volume":"173","author":"Silva","year":"2024","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0230","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"19","key":"10.1016\/j.cyto.2024.156732_b0235","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.1834400100","article-title":"CD4+ CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-\u03b2\u2013TGF-\u03b2 receptor interactions in type 1 diabetes","volume":"100","author":"Green","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"suppl_2","key":"10.1016\/j.cyto.2024.156732_b0240","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1073\/pnas.0404870101","article-title":"Unique role of CD4+ CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice","volume":"101","author":"You","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0245","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.4049\/jimmunol.176.8.4730","article-title":"Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo","volume":"176","author":"Weber","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0250","series-title":"Damage-Associated Molecular Patterns in Human Diseases: Volume 3: Antigen-Related Disorders","first-page":"569","article-title":"DAMPs in Organ-Specific Autoimmune Diseases","author":"Land","year":"2023"},{"issue":"4","key":"10.1016\/j.cyto.2024.156732_b0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2009.07.008","article-title":"T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event","volume":"31","author":"Lennon","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0260","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.2337\/db11-0375","article-title":"Early treatment of NOD mice with B7\u2013H4 reduces the incidence of autoimmune diabetes","volume":"60","author":"Wang","year":"2011","journal-title":"Diabetes"},{"issue":"656","key":"10.1016\/j.cyto.2024.156732_b0265","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg9170","article-title":"Exocrine pancreas regeneration modifies original pancreas to alleviate diabetes in mouse models","volume":"14","author":"Kou","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cyto.2024.156732_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109729","article-title":"Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes","volume":"255","author":"Li","year":"2023","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/db10-0104","article-title":"Interleukin-1\u03b2 produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: implications for the timing of tolerizing immunotherapy","volume":"60","author":"Bertin-Maghit","year":"2011","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0280","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.4049\/jimmunol.1201183","article-title":"Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation","volume":"189","author":"Kalim","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0285","series-title":"The manifold roles of immunoproteasome and short-chain fatty acids in shaping the anti-tumor immune responses: Die vielf\u00e4ltigen Auswirkungen des Immunoproteasoms und kurzkettiger Fetts\u00e4uren auf die Anti-Tumor-Immunit\u00e4t","author":"Leister","year":"2023"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20061631","article-title":"Dendritic cell\u2013expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice","volume":"204","author":"Tarbell","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.it.2007.11.001","article-title":"Toward cell-based therapy of type I diabetes","volume":"29","author":"Kabelitz","year":"2008","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0300","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41423-020-00623-2","article-title":"Induced regulatory T cells suppress Tc1 cells through TGF-\u03b2 signaling to ameliorate STZ-induced type 1 diabetes mellitus","volume":"18","author":"Zhou","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0305","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0310","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI78492","article-title":"Anti-thymocyte globulin\/G-CSF treatment preserves \u03b2 cell function in patients with established type 1 diabetes","volume":"125","author":"Haller","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0320","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0325","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","article-title":"Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes","volume":"54","author":"Brusko","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2004.11.004","article-title":"CD4+ CD25high regulatory T cells in human autoimmune diabetes","volume":"24","author":"Putnam","year":"2005","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2337\/db09-0694","article-title":"Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4+ CD25+ regulatory T-cells of type 1 diabetic subjects","volume":"59","author":"Long","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0345","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: increased Il-17\u2013secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0350","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0355","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4049\/jimmunol.2300527","article-title":"Rational engineering of islet tolerance via biomaterial-mediated immune modulation","volume":"212","author":"Klug","year":"2024","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0360","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/ITT.S417917","article-title":"Exploration of immune targets for type 1 diabetes and latent autoimmune disease immunotherapy","author":"Siddiqui","year":"2023","journal-title":"ImmunoTargets and Therapy"},{"key":"10.1016\/j.cyto.2024.156732_b0370","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2016.03.011","article-title":"Regulatory T cell therapy for type 1 diabetes: may the force be with you","volume":"71","author":"Gitelman","year":"2016","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbmt.2006.01.005","article-title":"Isolation of CD4+ CD25+ regulatory T cells for clinical trials","volume":"12","author":"Hoffmann","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0380","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2004-01-0151","article-title":"In vitro\u2013expanded human CD4+ CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell\u2013stimulated MLR cultures","volume":"104","author":"Godfrey","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0385","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+ CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0390","first-page":"2847","article-title":"Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4\u20131BB expressed on artificial antigen-presenting cells","volume":"112","author":"Hippen","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.cyto.2024.156732_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109716","article-title":"Umbilical cord blood and peripheral blood-derived regulatory T cells therapy: progress in type 1 diabetes","author":"Bi","year":"2023","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156732_b0400","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/eji.200790047","article-title":"Correction: IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655114","article-title":"Pathogenesis and function of interleukin-35 in rheumatoid arthritis","volume":"12","author":"Xin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0410","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0961203315585815","article-title":"Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus","volume":"24","author":"Cai","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4049\/jimmunol.1600506","article-title":"IL-35 suppresses lipopolysaccharide-induced airway eosinophilia in EBI3-deficient mice","volume":"198","author":"Kanai","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0420","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10753-016-0480-6","article-title":"Role of anti-inflammatory cytokines IL-35 and IL-37 in asthma","volume":"40","author":"Hu","year":"2017","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.cyto.2024.156732_b0425","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/leu.2014.310","article-title":"IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects","volume":"29","author":"Liu","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0430","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/db11-0784","article-title":"Prevention of autoimmune diabetes by ectopic pancreatic \u03b2-cell expression of interleukin-35","volume":"61","author":"Bettini","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0435","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cyto.2015.05.002","article-title":"Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes","volume":"75","author":"Mondanelli","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0440","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7727\/wimj.2014.008","article-title":"Resveratrol ameliorates diabetes-induced renal damage through regulating the expression of TGF-\u03b21, collagen IV and Th17\/Treg-related cytokines in rats","volume":"63","author":"Wenbin","year":"2014","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.cyto.2024.156732_b0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1219598","article-title":"Diabetic complications and prospective immunotherapy","volume":"14","author":"Reynolds","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0450","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/eji.201646493","article-title":"\u03b2-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice","volume":"47","author":"Manzoor","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0455","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cei\/uxac078","article-title":"Regulatory T-cell therapy approaches","volume":"211","author":"McCallion","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"14","key":"10.1016\/j.cyto.2024.156732_b0460","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.3390\/ijms23147970","article-title":"Interleukin-35 prevents the elevation of the M1\/M2 ratio of macrophages in experimental type 1 diabetes","volume":"23","author":"Luo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-019-0217-z","article-title":"IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling","volume":"16","author":"Jiang","year":"2019","journal-title":"J. Inflamm."},{"issue":"23","key":"10.1016\/j.cyto.2024.156732_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312988","article-title":"Interleukin-35 prevents development of autoimmune diabetes possibly by maintaining the phenotype of regulatory B cells","volume":"22","author":"Luo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156732_b0475","first-page":"1","article-title":"Advanced delivery strategies for immunotherapy in Type I diabetes mellitus","author":"Huang","year":"2023","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0480","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.13289","article-title":"Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes","volume":"197","author":"Singh","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0485","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2020.101510","article-title":"Decreased interleukin-35 levels and CD4+ EBI3+ T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab)","volume":"17","author":"Ouyang","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0490","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09273948.2016.1203959","article-title":"Levels of interleukin 27 and interleukin 35 in the serum and vitreous of patients with proliferative diabetic retinopathy","volume":"26","author":"Yan","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"24","key":"10.1016\/j.cyto.2024.156732_b0495","doi-asserted-by":"crossref","DOI":"10.7150\/thno.48264","article-title":"Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0500","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1080\/21655979.2022.2080367","article-title":"Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy","volume":"13","author":"Yan","year":"2022","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0505","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/jir.2015.0015","article-title":"Interleukin-35: expanding its job profile","volume":"35","author":"Sawant","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0510","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4067\/S0034-98872010000600015","article-title":"Interleukin (IL)-35 is raising our expectations","volume":"138","author":"Ning-Wei","year":"2010","journal-title":"Rev. Med. Chil."},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0515","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-023-01103-6","article-title":"A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.cyto.2024.156732_b0525","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00436-019-06247-4","article-title":"Helminths protect against type 1 diabetes: effects and mechanisms","volume":"118","author":"Tang","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cyto.2024.156732_b0530","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12016-014-8440-0","article-title":"Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review","volume":"47","author":"Tan","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156732_b0535","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what\u2019s broken and how can we fix it?","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0540","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156732_b0545","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.cyto.2024.156732_b0550","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+ CD25highCD127\u2212 regulatory T cells preserves \u03b2-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2024.156732_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109328","article-title":"Manufacturing regulatory T cells for adoptive cell therapy in immune diseases: a critical appraisal","author":"Abhishek","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0560","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead070","article-title":"Regulatory T cells: a new therapeutic link for Sj\u00f6gren syndrome?","author":"Ming","year":"2023","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.cyto.2024.156732_b0565","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156732_b0570","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2023.08.007","article-title":"Systems immunology of regulatory T cells: can one circuit explain it all?","author":"Tripathi","year":"2023","journal-title":"Trends Immunol."},{"issue":"7169","key":"10.1016\/j.cyto.2024.156732_b0580","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"issue":"7129","key":"10.1016\/j.cyto.2024.156732_b0585","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156732_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712870","article-title":"Antigen-specific treg therapy in type 1 diabetes\u2013challenges and opportunities","volume":"12","author":"Serr","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0595","article-title":"The alterations in and the role of the Th17\/Treg balance in metabolic diseases","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156732_b0600","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.20051409","article-title":"Where CD4+ CD25+ T reg cells impinge on autoimmune diabetes","volume":"202","author":"Chen","year":"2005","journal-title":"J. Exp. Med."},{"issue":"18","key":"10.1016\/j.cyto.2024.156732_b0605","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1073\/pnas.1103782108","article-title":"CD4+ CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis","volume":"108","author":"McNally","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0610","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0615","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1026","article-title":"Regulatory T cells under scrutiny","volume":"3","author":"Francois Bach","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189617","article-title":"Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg\/Th17 ratio","volume":"12","author":"Zongyi","year":"2017","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156732_b0625","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","article-title":"Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0630","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0635","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2024.156732_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101809","article-title":"The beta cell-immune cell interface in type 1 diabetes (T1D)","author":"James","year":"2023","journal-title":"Mol. Metab."},{"issue":"7","key":"10.1016\/j.cyto.2024.156732_b0645","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.3390\/ijms24076331","article-title":"The role of LFA-1 for the differentiation and function of regulatory T cells\u2014lessons learned from different transgenic mouse models","volume":"24","author":"Klaus","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7492","key":"10.1016\/j.cyto.2024.156732_b0650","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cyto.2024.156732_b0655","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00109-009-0516-6","article-title":"The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies","volume":"87","author":"Faustman","year":"2009","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0660","article-title":"Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1\/Th17 and upregulation of Foxp3+ Treg","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2024.156732_b0665","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.21037\/tcr.2019.07.30","article-title":"IL-35 inhibits CD8+ T cells activity by suppressing expression of costimulatory molecule CD28 and Th1 cytokine production","volume":"8","author":"Jiang","year":"2019","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0670","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3892\/ijmm.2016.2688","article-title":"Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines","volume":"38","author":"Hou","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0675","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00125-005-0133-z","article-title":"Phosphorylation of c-Jun N-terminal kinase (JNK) in sensory neurones of diabetic rats, with possible effects on nerve conduction and neuropathic pain: prevention with an aldose reductase inhibitor","volume":"49","author":"Middlemas","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2024.156732_b0680","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0685","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00792","article-title":"Macrophage polarization in physiological and pathological pregnancy","volume":"10","author":"Yao","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156732_b0690","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2024.156732_b0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00479","article-title":"\u201cOf mice and men\u201d: arginine metabolism in macrophages","volume":"5","author":"Thomas","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156732_b0700","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0705","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/CS20201348","article-title":"Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3\/iNOS pathway and attenuated by docosahexaenoic acid","volume":"135","author":"Davanso","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cyto.2024.156732_b0710","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156732_b0715","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.humimm.2013.01.024","article-title":"Loss of the balance between CD4+ Foxp3+ regulatory T cells and CD4+ IL17A+ Th17 cells in patients with type 1 diabetes","volume":"74","author":"Ryba-Stanis\u0142awowska","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2024.156732_b0720","series-title":"Metal Nanocomposites in Nanotherapeutics for Oxidative Stress-Induced Metabolic Disorders","first-page":"1","article-title":"Oxidative stress-induced metabolic disorders: Mechanism and pathogenesis","author":"Sen","year":"2024"},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0725","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1053\/j.gastro.2011.07.040","article-title":"Interleukin-35 mediates mucosal immune responses that protect against T-cell\u2013dependent colitis","volume":"141","author":"Wirtz","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaci.2011.08.009","article-title":"IL-35 production by inducible costimulator (ICOS)\u2013positive regulatory T cells reverses established IL-17\u2013dependent allergic airways disease","volume":"129","author":"Whitehead","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156732_b0735","first-page":"820","article-title":"IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis","volume":"37","author":"Liu","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156732_b0740","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000504197","article-title":"IL-35 inhibited Th17 response in children with allergic rhinitis","volume":"82","author":"Xie","year":"2020","journal-title":"ORL"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:14:21Z","timestamp":1724454861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":148,"alternative-id":["S1043466624002357"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156732","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156732"}}